ArticleScientific reports2017

A Toxic Conformer of Aβ42 with a Turn at 22-23 is a Novel Therapeutic Target for Alzheimer's Disease.

Naotaka Izuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.